Selective serotonin reuptake inhibitor use and risk of gestational hypertension

被引：0
|
作者：
Toh, Sengwee [1 ]
Mitchell, Allen A. [2 ]
Chambers, Christina D. [3 ]
Louik, Carol [2 ]
Werler, Martha M. [2 ]
Hemandez-Diaz, Sonia [1 ,2 ]
机构：
[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[2] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA
[3] UCSD, San Diego, CA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
033
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [1] Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension
    Toh, Sengwee
    Mitchell, Allen A.
    Louik, Carol
    Werler, Martha M.
    Chambers, Christina D.
    Hernandez-Diaz, Sonia
    AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (03): : 320 - 328
  • [2] Serotonin Reuptake Inhibitor and Pregnancy: Risk of Gestational Hypertension?
    Damase-Michel, Christine
    Duhalde, Veronique
    Hurault, Caroline
    Bourrel, Robert
    Montastruc, Jean Louis
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S13 - S13
  • [3] Serotonin reuptake inhibitor and pregnancy: Risk of gestational hypertension?
    Damase-Michel, C.
    Duhalde, V.
    Delarue, C.
    Lacroix, I.
    Bourrel, R.
    Montastruc, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 51 - 51
  • [4] Association of Risk of Small for Gestational Age with Selective Serotonin Reuptake Inhibitor Use
    Hwang, Yeon Mi
    Piekos, Samantha
    Baloni, Priyanka
    Hood, Leroy
    Hadlock, Jennifer
    REPRODUCTIVE SCIENCES, 2022, 29 (SUPPL 1) : 82 - 82
  • [5] Prenatal Selective Serotonin Reuptake Inhibitor Use and Associated Risk for Gestational Hypertension and Preeclampsia: A Meta-Analysis of Cohort Studies
    Guan, Hong-Bo
    Wei, Yang
    Wang, Lei-Lei
    Qiao, Chong
    Liu, Cai-Xia
    JOURNAL OF WOMENS HEALTH, 2018, 27 (06) : 791 - 800
  • [6] Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma
    Lai, Shih-Wei
    Hwang, Bing-Fang
    Liu, Chiu-Shong
    Liao, Kuan-Fu
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (07) : 1197 - 1198
  • [7] Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma
    Shih-Wei Lai
    Bing-Fang Hwang
    Chiu-Shong Liu
    Kuan-Fu Liao
    European Journal of Clinical Pharmacology, 2022, 78 : 1197 - 1198
  • [8] Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension
    Kawut, Steven M.
    Horn, Evelyn M.
    Berekashvili, Ketevan K.
    Lederer, David J.
    Widlitz, Allison C.
    Rosenzweig, Erika B.
    Barst, Robyn J.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (05) : 370 - 374
  • [9] Selective Serotonin Reuptake Inhibitor Use and Risk of Gastrointestinal and Intracranial Bleeding
    Yuet, Wei Cheng
    Derasari, Dhvani
    Sivoravong, Jon
    Mason, David
    Jann, Michael
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2019, 119 (02): : 102 - 111
  • [10] Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Risk of Postpartum Hemorrhage
    Andrade, Chittaranjan
    JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (02)
12345